Ross Andrew L. 4

Accession 0001104659-21-084775

CIK 0001558569other

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 9:35 PM ET

Size

30.2 KB

Accession

0001104659-21-084775

Insider Transaction Report

Form 4

Period: 2021-06-21

iSpecimen Inc.ISPC

Ross Andrew L.

Director10% Owner

Transactions

Conversion
Common Stock
2021-06-21+355,005→ 719,346 total
Conversion
Common Stock
2021-06-21+13,985→ 1,310,524 total(indirect: By Trust)
Other
Bridge Note
2021-06-21+39→ 13,985 total(indirect: By Trust)
Exp: 2021-06-30→ Common Stock (39 underlying)
Conversion
Bridge Note
2021-06-21−13,985→ 0 total(indirect: By Trust)
Exercise: $5.60Exp: 2021-06-30→ Common Stock (13,985 underlying)
Conversion
Convertible Note
2021-06-21−360,674→ 0 total
Exercise: $5.60Exp: 2021-06-30→ Common Stock (360,674 underlying)
Conversion
Common Stock
2021-06-21+130,081→ 849,427 total
Conversion
Common Stock
2021-06-21+360,674→ 1,210,101 total
Conversion
Common Stock
2021-06-21+86,438→ 1,296,539 total
Conversion
Series B Preferred Stock
2021-06-21−130,081→ 0 total
→ Common Stock (130,081 underlying)
Other
Bridge Note
2021-06-21+2,420→ 86,438 total
Exp: 2021-06-30→ Common Stock (2,420 underlying)
Conversion
Series A Preferred Stock
2021-06-21−355,005→ 0 total
→ Common Stock (355,005 underlying)
Other
Convertible Note
2021-06-21+231→ 360,674 total
Exp: 2021-06-30→ Common Stock (231 underlying)
Conversion
Bridge Note
2021-06-21−86,438→ 0 total
Exercise: $5.60Exp: 2021-06-30→ Common Stock (86.438 underlying)

Footnotes (11)

[F1]Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.
[F10]Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note.
[F11]Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note.
[F2]Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion.
[F3]Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person.
[F4]Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.
[F5]Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.
[F6]Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date.
[F7]The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO.
[F8]The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO.
[F9]The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO.

Documents

1 file

4
tm2120463-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

iSpecimen Inc.

CIK 0001558569

→

Entity typeother

Related Parties

filerCIK 0001857013

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 9:35 PM ET
Size: 30.2 KB

View on SEC.gov